Latest News and Press Releases
Want to stay updated on the latest news?
-
IRVINE, Calif., Jan. 03, 2018 (GLOBE NEWSWIRE) -- TRIMEDYNE, INC. (OTCPINK “TMED”) today reported its financial results for its Fiscal Year ending on September 30, 2017. For the Fiscal Year Ended...
-
LAKE FOREST, Calif., Dec. 26, 2006 (PRIME NEWSWIRE) -- Trimedyne, Inc. (OTCBB:TMED) today reported a profit of $97,000 or $0.01 per share on revenues of $6,237,000 for its fiscal year ended September...
-
IRVINE, Calif., May 21, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today reported a net profit of $149,000 or $0.01 per share, fully diluted, on net revenues from sales and other income...
-
IRVINE, Calif., May 3, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its 80 Watt Holmium Laser and Re-usable Optical Fibers are eligible for Medicare's new reimbursement rate for...
-
IRVINE, Calif., March 31, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced that Marvin P. Loeb, Chairman of Trimedyne, was interviewed by Diane Reynolds of CEO/CFO Interviews. A...
-
IRVINE, Calif., March 15, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced the U.S. Patent Office has allowed 24 claims of its patent application on a new Laser Angioplasty Catheter...
-
Trimedyne Receives U.S. Patent Office Allowance of Important Patent to Treat Heart Valve Malfunction
IRVINE, Calif., March 4, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced the U.S. Patent Office has allowed 17 claims of its patent application on a new Laser Balloon Catheter...
-
IRVINE, Calif., Feb. 4, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its Chairman, Marvin P. Loeb, was interviewed by Ian Roberts of the Wall Street Reporter. The audio interview...
-
IRVINE, Calif., Jan. 28, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today announced its chairman, Marvin P. Loeb, was interviewed by MacReport.Net. The interview will be available by visiting...
-
IRVINE, Calif, Jan. 14, 2004 (PRIMEZONE) -- Trimedyne, Inc. (OTCBB:TMED) today reported a net profit of $1,034,000 or $0.08 per share ($0.07 per share fully diluted) on revenues of $6,459,000 for the...